featured
Real-Life Omalizumab Exposure and Discontinuation in Pediatric and Adult Patients With Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The European Respiratory Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of paediatric and adult asthma patients
Eur. Respir. J. 2022 Nov 01;[EPub Ahead of Print], M Humbert, A Bourdin, C Taillé, D Kamar, C Thonnelier, A Lajoinie, A Rigault, A Deschildre, M MolimardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.